$22.80
1.13% today
Nasdaq, Feb 28, 09:16 pm CET
ISIN
US4579852082
Symbol
IART

Integra LifeSciences Holdings Corporation Target price 2025 - Analyst rating & recommendation

Integra LifeSciences Holdings Corporation Classifications & Recommendation:

Buy
17%
Hold
50%
Sell
33%

Integra LifeSciences Holdings Corporation Price Target

Target Price $26.25
Price $23.06
Potential
Number of Estimates 8
8 Analysts have issued a price target Integra LifeSciences Holdings Corporation 2026 . The average Integra LifeSciences Holdings Corporation target price is $26.25. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 2 Analysts recommend Integra LifeSciences Holdings Corporation to buy, 6 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Integra LifeSciences Holdings Corporation stock has an average upside potential 2026 of . Most analysts recommend the Integra LifeSciences Holdings Corporation stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 1.61 1.68
4.47% 4.28%
EBITDA Margin 16.80% 19.77%
24.75% 17.69%
Net Margin -0.43% 4.29%
110.26% 1,094.80%

11 Analysts have issued a sales forecast Integra LifeSciences Holdings Corporation 2025 . The average Integra LifeSciences Holdings Corporation sales estimate is

$1.7b
Unlock
. This is
4.28% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.7b 4.69%
Unlock
, the lowest is
$1.7b 3.64%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.6b 4.47%
2025
$1.7b 4.28%
Unlock
2026
$1.8b 4.31%
Unlock
2027
$1.8b 4.01%
Unlock

7 Analysts have issued an Integra LifeSciences Holdings Corporation EBITDA forecast 2025. The average Integra LifeSciences Holdings Corporation EBITDA estimate is

$332m
Unlock
. This is
21.82% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$337m 23.79%
Unlock
, the lowest is
$315m 15.63%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $271m 21.39%
2025
$332m 22.71%
Unlock
2026
$357m 7.64%
Unlock
2027
$377m 5.37%
Unlock

EBITDA Margin

2024 16.80% 24.75%
2025
19.77% 17.69%
Unlock
2026
20.40% 3.19%
Unlock
2027
20.66% 1.27%
Unlock

3 Integra LifeSciences Holdings Corporation Analysts have issued a net profit forecast 2025. The average Integra LifeSciences Holdings Corporation net profit estimate is

$72.0m
Unlock
. This is
1,137.10% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$102m 1,566.60%
Unlock
, the lowest is
$54.0m 877.79%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-6.9m 110.71%
2025
$72.0m 1,137.10%
Unlock
2026
$85.4m 18.56%
Unlock

Net Margin

2024 -0.43% 110.26%
2025
4.29% 1,094.80%
Unlock
2026
4.87% 13.52%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.09 0.93
110.71% 1,133.33%
P/E 24.71
EV/Sales 2.08

3 Analysts have issued a Integra LifeSciences Holdings Corporation forecast for earnings per share. The average Integra LifeSciences Holdings Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.93
Unlock
. This is
1,133.33% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.32 1,566.67%
Unlock
, the lowest is
$0.70 877.78%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.09 110.71%
2025
$0.93 1,133.33%
Unlock
2026
$1.11 19.35%
Unlock

P/E ratio

Current -254.81 796.77%
2025
24.71 109.70%
Unlock
2026
20.84 15.66%
Unlock

Based on analysts' sales estimates for 2025, the Integra LifeSciences Holdings Corporation stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.17 31.76%
2025
2.08 4.19%
Unlock
2026
1.99 4.13%
Unlock
2027
1.92 3.85%
Unlock

P/S ratio

Current 1.11 51.23%
2025
1.06 4.10%
Unlock
2026
1.02 4.13%
Unlock
2027
0.98 3.86%
Unlock

Current Integra LifeSciences Holdings Corporation Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citizens Capital Markets Locked ➜ Locked Locked Feb 26 2025
Citigroup Locked ➜ Locked Locked Nov 05 2024
Truist Securities Locked ➜ Locked Locked Oct 14 2024
B of A Securities Locked ➜ Locked Locked Oct 07 2024
BTIG Locked ➜ Locked Locked Oct 07 2024
Citigroup Locked ➜ Locked Locked Oct 01 2024
BTIG Locked ➜ Locked Locked Aug 28 2024
Analyst Rating Date
Locked
Citizens Capital Markets: Locked ➜ Locked
Feb 26 2025
Locked
Citigroup: Locked ➜ Locked
Nov 05 2024
Locked
Truist Securities: Locked ➜ Locked
Oct 14 2024
Locked
B of A Securities: Locked ➜ Locked
Oct 07 2024
Locked
BTIG: Locked ➜ Locked
Oct 07 2024
Locked
Citigroup: Locked ➜ Locked
Oct 01 2024
Locked
BTIG: Locked ➜ Locked
Aug 28 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today